Principal Financial Group
PTX

Principal Financial Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Principal Financial Group’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,261
Closed -$13K – 2242
2016
Q1 		$13K Buy
+1,261
New +$25.1K ﹤0.01% 2166
2015
Q3 		– Sell
-1,188
Closed -$70K – 2252
2015
Q2 		$70K Buy
+1,188
New +$83.8K ﹤0.01% 2155
2014
Q4 		– Sell
-1,087
Closed -$83K – 2262
2014
Q3 		$83K Hold
1,087
– – ﹤0.01% 2159
2014
Q2 		$98K Buy
+1,087
New +$66.6K ﹤0.01% 2204

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Principal Financial Group's PTX Position: Q2 2016 in Review

Principal Financial Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 1,261 shares — an estimated $13K sold.

Principal Financial Group first reported a position in PTX in Q2 2014 and held it in 4 quarters. The position peaked at $98K in Q2 2014. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • Principal Financial Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Principal Financial Group sold 1,261 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $13K.
  • Principal Financial Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 4 quarters.
  • Principal Financial Group's Pernix Therapeutics Holdings, Inc. position peaked at $98K in Q2 2014.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Principal Financial Group's 13F filing for Q2 2016, filed 9 Aug 2016.